Federal prosecutors have charged numerous New York pharmacy owners and employees with criminal violations relating to OTC card exchanges and nominal benefits. Because these practices are widespread, providers should act immediately to limit their exposure as the crackdown expands.
Government’s Healthcare Fraud Investigation
At the time of this update, the federal government has filed criminal charges against numerous pharmacy owners and employees for violations of the Anti-Kickback Statute and Healthcare Fraud relating to OTC card exchanges and nominal benefits, including $3 supermarket coupons, $2 in-store credits, and waivers of $3 copayments.
The government alleges in these cases that patients, pharmacies, and physicians all participated in a loop of bribery, referrals and billing fraud. These charges are severe and carry prison terms of up to 10 years’ incarceration.
Healthcare Fraud Based on OTC Benefits
Specifically, the government alleges that patients were paid kickbacks by pharmacies in the form of OTC and other common benefits, such as co-pay waivers.
The pharmacies then allegedly referred their patients to physicians, who wrote medically unnecessary prescriptions for high-reimbursing drugs and DME. The patients, in turn, returned to the referring pharmacies, where the prescriptions were filled to the tune of tens of millions of dollars in federal reimbursement.
Although the government has yet to unveil charges against physicians who participated in the scheme, those charges have either been filed under seal and the physicians are cooperating, or they will be filed publicly soon.
Healthcare Fraud Theory of Prosecution
Notably, the theory of prosecution in these cases is incredibly broad. For example, the government alleges that “a common means of providing kickbacks and bribes to Medicare beneficiaries and Medicaid recipients and facilitating fraud schemes for medically unnecessary medications is to fail to charge such individuals the copayments due for their prescriptions.”
On the other hand, the OIG has recognized that copay waivers may be appropriate based on individualized assessments of financial need, and has never charged a patient with receiving a so-called bribe in the form of a co-pay waiver.
Accordingly, the sweeping charging theory in these cases means that a pharmacist may be criminally charged if he or she has waived copays or offered other nominal benefits to customers, such as accepting OTC cards for non-eligible items, who then filled medically unnecessary prescriptions, irrespective of whether the pharmacist knew the order lacked medical necessity.
This exposure is troubling for a number of reasons. First, pharmacists typically have no insight whatsoever into whether a prescribed drug is medically necessary to treat a patient’s condition. Second, the circumstances in which a pharmacist can legally refuse to fill a prescription vary, and may depend on state law. Third, despite the prevalence of co-pay waivers and OTC violations throughout the industry, federal prosecutors are using data to target “outlier” pharmacies without regard to customer base or underlying patient conditions.
HLA Specializes in Healthcare Fraud Defense
In short, if your pharmacy has offered nominal benefits involving OTC cards and co-pay waivers to customers, you may have criminal exposure. There are a number of immediate steps that clients can take to better understand and limit that risk. At Health Law Alliance, our experienced healthcare defense attorneys have represented numerous clients under federal investigation for the practices described in this article. Our firm’s mission is simple: use unmatched experience and insight to defend our clients against insurance conglomerates, the federal government, and state agencies. We used to work for them. Now let us fight for you. Contact us today for a COMPLIMENTARY consultation. We can help.
Common PBM Audit Triggers and How to Avoid Them
Guide independent pharmacies in recognizing and proactively managing specific behaviors and operational trends that commonly lead to PBM audits. This article will offer a detailed watchlist of PBM audit triggers and present practical, actionable steps for minimizing risks of audit findings and compliance issues.
Read More >>Navigating Informed Consent Requirements in Telehealth: A Provider’s Guide
We examine the complex requirements and risks associated with informed consent for telehealth providers. The article provides actionable advice on navigating the regulatory landscape and practical steps to ensure legal compliance and patient safety.
Read More >>Pennsylvania Board Closes Investigation of HLA Client with No Action
Telemedicine business models may prompt regulatory scrutiny, including board investigations. In this case, HLA's experienced defense attorneys successfully resolved a three-year, multi-state investigation with no licensing or other implications.
Read More >>Department of Justice Declines to Prosecute HLA Client for Alleged $6M Fraud
After the Department of Justice threatened to indict our client for involvement in an alleged $6M healthcare fraud, we stood firm and our tenacious advocacy ultimately convinced the Strike Force to decline prosecution, representing a complete win for HLA's client.
Read More >>